Centiva Capital, LP Bruker Corp Transaction History

Centiva Capital, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$61.34 - $75.77 $52,752 - $65,162	860 Added 17.21%	5,857 $364,000
Q2 2023 Aug 14, 2023	BUY	$69.1 - $84.02 $345,292 - $419,847	4,997 New	4,997 $369,000
Q4 2021 Feb 14, 2022	SELL	$74.85 - $85.37 $221,406 - $252,524	-2,958 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$76.52 - $91.36 $409,152 - $488,501	-5,347 Reduced 64.38%	2,958 $231,000
Q2 2021 Aug 16, 2021	BUY	$64.92 - $75.99 $174,894 - $204,717	2,694 Added 48.01%	8,305 $631,000
Q1 2021 May 17, 2021	BUY	$53.31 - $64.28 $299,122 - $360,675	5,611 New	5,611 $361,000
Q4 2020 Feb 16, 2021	SELL	$38.78 - $55.48 $341,070 - $487,946	-8,795 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$38.34 - $46.17 $337,200 - $406,065	8,795 New	8,795 $350,000

386

101M

33K

39.5K

Ticker BRKR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 148,138,000
Market Cap $8.56B
Description
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, ...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.